Studies

Anti-interferon autoantibodies in COVID-19: a UKRI CIC study

Speciality area
Infection, COVID

Study type
Samples and data

Researcher type
Academic

Research lead
Dr Rainer Doffinger

Determining ethnic differences in IBD phenotype and response to treatment; determining differences in disease course and management of IBD in the elderly

Speciality area
Gastroenterology

Study type
Data only

Researcher type
Academic

Research lead
Dr Sharmili Balarajah

Use of long-read nanopore sequencing and short-read whole genome sequencing to resolve individuals with antithrombin deficiency, a rare disease which increase the risk of thrombosis, with unknown molecular base.

Speciality area
Genomics and Rare Diseases, Haematology

Study type
Data only

Researcher type
Academic

Research lead
Belen de la Morena-Barrio

GlyHealth-COVID: A precision medicine test to identify ImmunoFrail patients at high risk of becoming severely ill or dying from COVID-19

Speciality area
Infection, COVID

Study type
Participant re-contact

Researcher type
Commercial

Research lead
Dr Daniel Spencer

NEW UK VARIANT AND EVALUATION OF ANTIBODY ESCAPE

Speciality area
Infection

Study type
Samples and data

Researcher type
Non-commercial

Research lead
Ravi Gupta

Cardiopulmonary exercise testing following COVID-19 infection

Speciality area
Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Dr Jonathan Fuld

Immune responses in convalescent Asymptomatic and Symptomatic COVID19 individuals

Speciality area
Infection

Study type
Samples and data

Researcher type
Non-commercial

Research lead
Dr Mark Wills

Serological mechanisms underlying cardiotoxicity in COVID-19

Speciality area
Cardiovascular Disease, Infection

Study type
Samples and data

Researcher type
Non-commercial

Research lead
Dr. Sanjay Sinha

Assessment of efficacy and adverse events following SARS-CoV-2 cohort of subjects previously infected with COVID-19

Speciality area
Infection

Study type
Participant re-contact

Researcher type
Non-commercial

Research lead
Dr James Thaventhiran